Clarivate IPOne

What it is

IPOne is Clarivate’s umbrella for putting AI agents on top of the IP data it already sells: Derwent patent records, Darts-ip litigation data, and CompuMark trademark and design data. Clarivate announced it on 29 May 2026 with three parts. IPOne Insights is conversational search. IPOne Workflow Agents are patent and trademark agents for clearance, patentability, portfolio and competitive analysis, litigation risk, and technology landscaping. IPOne AI Ecosystem Access is a set of MCP servers that pipe the same data into Claude, ChatGPT, and Microsoft Copilot.

The data behind it is the real asset. Clarivate’s IPOne page cites 180 million patent publications across 109 jurisdictions, 168 million-plus marks from 188 trademark databases, and 12 million-plus verified IP cases. Derwent’s hand-written abstracts and family groupings are why litigators already trust a Derwent search record.

Read the launch carefully, though. Clarivate’s own product page describes IPOne as a vision for a single IP intelligence ecosystem spanning patents, trademarks, and litigation, not a finished suite. What you can actually connect today is narrower than the press release suggests:

• CompuMark Trademark MCP — listed in Anthropic’s official Claude connector directory since 7 June 2026, and Clarivate has since announced it for ChatGPT as well. It exposes nine tools, including trademark search, knockout search, counts, full text, goods and services, and register office codes. Documentation sits at https://ipone.clarivate.com/trademarks/mcp/docs, and sign-in runs against an existing CompuMark account.
• Darts-ip Litigation MCP — a product page names Copilot, Claude, and ChatGPT as targets for querying case law. We found no public connector-directory listing to confirm it the way the trademark server is confirmed.
• Derwent Patent Search (formerly Derwent Innovation) — AI search over the Derwent World Patents Index, plus Derwent Patent Monitor, launched 24 November 2025 for collaborative patentability, FTO, and opposition reviews. Clarivate’s menu lists a Derwent Patent MCP, but we found no public listing for it.

The corporate context matters to the buyer. On 6 October 2026 Clarivate closed the $600M sale of its Life Sciences & Healthcare segment to Altaris and now runs two segments: Academia & Government, and IP. IPOne is the flagship of the remaining IP business. The upside is that it gets investment. The downside is that it carries revenue expectations: IP recurring organic revenue only got back to flat in Q2 2026.

Pricing reality

Nothing is published. IPOne, Derwent, and CompuMark are all quote-only, and the MCP servers authenticate against an existing Clarivate entitlement, not a self-serve signup. In practice, IPOne access is an extension of a data contract you already hold or are about to negotiate.

The only external anchors are weak. GleanMark, a competing trademark tool, puts CompuMark at $5K–50K+ a year for SAEGIS subscriptions or about $745 per full search. Treat that as a competitor’s sales claim, not a quote. Review directories place Derwent at the high end of the patent-research market without giving a figure. For comparison, buyer-reported PatSnap Analytics entry contracts run roughly $15K–30K a year for a few seats. Expect a Derwent quote above that, not below.

Put three things in the order form: which IPOne components are generally available on your contract date and which are early access; whether MCP calls are included in your seats or metered; and the data-use terms for results returned into a third-party LLM such as Claude or Copilot.

Best for

In-house IP counsel and IP operations leads at corporations that already license Derwent or CompuMark. Their teams have standardized on Claude, ChatGPT, or Copilot, and they want clearance and litigation-risk lookups inside that assistant instead of a separate search seat. The clearest early use case is trademark knockout screening from a Claude or Copilot chat, backed by CompuMark data your brand team already trusts.

Not for you if you have no Clarivate contract today. Starting one to get IPOne is buying the data layer at full enterprise price in order to reach agents that are partly still on the roadmap. It is also not for you if the job is drafting applications or building claim charts. IPOne searches and analyzes. It does not produce attorney work product.

Alternatives — and when to pick them instead

• PatSnap — the other incumbent by market share in patent data, and further ahead on agents: Eureka ships domain agents, and the vendor advertises 30+ MCP servers plus a credit-priced Open Platform with a free starter tier. Pick it when you want to prototype agent workflows this quarter without an enterprise contract first.
• Questel — the European-origin incumbent, with Orbit search and the Qthena AI assistant. Pick it when EPO and WIPO prosecution is the center of gravity, or to put a competing quote next to Clarivate’s.
• Patlytics — the fastest-growing AI-native entrant on the analysis side, with a $40M Series B in April 2026 and a public MCP server at https://mcp.patlytics.ai/mcp. Pick it when the deliverable is an evidence-of-use or invalidity claim chart rather than a search report.
• Solve Intelligence or DeepIP — pick these when the job is drafting and prosecution, not search. They sit downstream of a data license; they do not replace one.
• Anaqua — pick it when the problem is docketing, annuities, and portfolio records, not intelligence. Clarivate’s own answer there is IPfolio, a separate product from IPOne.

Watch-outs

• The announcement is ahead of the product. Clarivate frames IPOne as a vision, only the trademark MCP has a confirmed public directory listing, and no customer adoption numbers have been published. Guard: before signing, require a written list of the IPOne components that are generally available on your contract date. Make anything else a no-cost option you can decline, never a reason for the price.
• Your MCP connection follows your existing entitlement. Authentication runs through ipone.clarivate.com against your CompuMark or Derwent account, so an agent can only reach the data you already license. Losing that contract cuts off the workflows you built on it. Guard: pilot with the CompuMark Trademark MCP on one brand team for 30 days and log the call volume, then negotiate MCP access and rate limits as a named line item at renewal.
• Results leave Clarivate’s environment. An MCP answer lands inside a third-party assistant’s context and logs, and clearance queries can reveal unannounced product names. Guard: connect only through enterprise tenants with retention controls, and have counsel approve which matters may be queried through which assistant before rollout.
• Corporate restructuring changes the renewal conversation. Clarivate is deleveraging after the Altaris sale, and IP revenue has only just returned to flat. Guard: cap renewal uplift at signing and tie any IPOne price step to features that are already generally available, not to the roadmap.